Results for 'Epoetin'

The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions
Mar 12th • 7 mins read

Addressing oncologists' gaps in the use of biosimilar products
Jun 19th • 5 mins read